BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 30, 2020
View Archived Issues
iPSCs find best therapy for Best disease
Read More
Terns and Hansoh enter collaboration and license agreement for TRN-000632 in Greater China
Read More
Proof of concept seen with CAR T cells targeting chondroitin sulfate for treating bladder cancer
Read More
Bayer presents promising preclinical and phase I data for BAY-2433334
Read More
Novel mouse model of AAA with intraluminal thrombus
Read More
Kyorin Pharmaceutical discloses new 15-hydroxyprostaglandin dehydrogenase inhibitors
Read More
New MGAT2 inhibitors discovered at Shionogi
Read More
Incyte synthesizes new STING receptor agonists
Read More
Lilly discovers interleukin-17 receptor A antagonists
Read More
Genetic variant combination in MPIG6B and SH2B3 genes leads to myelofibrosis and thrombocytopenia
Read More
Astrogen identifies new serine derivatives
Read More
Screening in serum yields potential antibiotics against drug-resistant K. pneumoniae
Read More
Positive topline data presented from phase IIa ACTION study of DMX-200 in FSGS
Read More
Apogenix receives regulatory approval in Russia for phase II study of asunercept in COVID-19
Read More
Arrowhead initiates phase II study of AMG-890
Read More
First patient dosed in phase I/II study of RP-3500
Read More
Constant Therapeutics initiates phase II study of TXA-127 for COVID-19
Read More
Enterome begins clinical evaluation of cancer multipeptide therapeutic vaccine EO-2401
Read More
Phase I trial evaluates IBS therapy SMP-100 in healthy volunteers
Read More
INSPIRE trial of rigosertib reaches required survival events for data analysis
Read More
Noxopharm advances Veyonda for prostate cancer and COVID-19
Read More
ONC-392 moves into first-in-human study in advanced solid tumors and NSCLC
Read More
AL-001 normalizes progranulin levels in patients with GRN gene-mutation frontotemporal dementia
Read More